Research shows semaglutide users face a significantly higher risk of developing non-arteritic anterior ischemic optic neuropathy (NAION) compared to users of other medications for diabetes and obesity.
Semaglutide linked to increased risk of severe eye condition NAION in new study
- Post author:
- Post published:July 8, 2024
- Post category:uncategorized